<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04177628</url>
  </required_header>
  <id_info>
    <org_study_id>DBCG RT SDM</org_study_id>
    <nct_id>NCT04177628</nct_id>
  </id_info>
  <brief_title>Shared Decision Making With Breast Cancer Patients</brief_title>
  <official_title>Shared Decision Making With Breast Cancer Patients Offered Adjuvant Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vejle Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Breast Cancer Cooperative Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vejle Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to elucidate whether the use of shared decision making will&#xD;
      influence patient engagement in the decision making process about adjuvant radiotherapy after&#xD;
      breast conserving surgery for local breast cancer or early stages of local breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The risk of recurrence of breast cancer is lowered by adjuvant medical treatment as well as&#xD;
      by radiotherapy (RT). On the other hand, all adjuvant treatments involve a risk of side&#xD;
      effects; some are acute and transient while others are long-term. Considering the well-known&#xD;
      side effects of irradiation, it seems appropriate to involve patients in the decision on&#xD;
      whether to receive irradiation.&#xD;
&#xD;
      In the shared decision making (SDM) process clinicians and patients work together to make&#xD;
      appropriate health decisions based on clinical evidence and the patient's informed&#xD;
      preferences. A patient decision aid (PtDA) is instrumental in the SDM process.&#xD;
&#xD;
      This study is a multicenter, national trial randomizing doctors to either use or not use SDM&#xD;
      and a PtDA when informing the patients about benefits and risks of receiving adjuvant&#xD;
      radiotherapy.&#xD;
&#xD;
      It is not expected that significantly less patients will receive radiotherapy as a&#xD;
      consequence of SDM. The primary aim of the study is to evaluate whether patient engagement in&#xD;
      decision making is affected by SDM and the use of an in-consultation PtDA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2020</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Half the doctors at each center will receive training in SDM. These doctors will practice SDM supported by the in-consultation PtDA during every consultation in this study. The other half of the doctors will continue usual practice of informing the patients.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participant engagement in the decision making process as measured by the Shared Decision Making Questionnaire 9.</measure>
    <time_frame>Within one week after the consultation</time_frame>
    <description>Minimum value: 0. Maximum value: 100. The higher the value the more patient engagement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The doctor's perception of patient engagement in the decision making process as measured by the Shared Decision Making Questionnaire doctor 9</measure>
    <time_frame>Within one week after the consultation</time_frame>
    <description>Minimum value: 0. Maximum value: 100. The higher the value the more patient engagement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participant's fear of cancer recurrence as measured by the Fear of Cancer Recurrence Short form Questionnaire</measure>
    <time_frame>Within one week after the consultation and again after six months</time_frame>
    <description>Minimum value: 0. Maximum value: 36. The higher the value the more fear of recurrence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participant's engagement in the decision making process as measured by the Shared Decision Making Process 4 questionnaire</measure>
    <time_frame>Within one week after the consultation</time_frame>
    <description>Minimum score: 0. Maximum score: 4. The higher the score the more patient engagement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participant's effectiveness in decision making as measured by the Decisional Conflict Scale questionnaire</measure>
    <time_frame>Before (12 items) and within one week after the consultation (all 16 items)</time_frame>
    <description>Minimum value: 0. Maximum value: 100. The higher the value the more effective decision making.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participant's regret of the treatment decision as measured by the Decision Regret Scale questionnaire</measure>
    <time_frame>Six months after the consultation</time_frame>
    <description>Minimum value: 0. Maximum value: 100. The higher the value the more regret.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participant's engagement in the decision making process as measured by the CollaboRATE questionnaire</measure>
    <time_frame>Within one week after the consultation</time_frame>
    <description>Minimum score: 0. Maximum score: 9. The higher the value the more patient engagement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participant's quality of life as measured by the EORCT QLQ-C30 (version 3.0) questionnaire, only question 29 + 30</measure>
    <time_frame>Six months</time_frame>
    <description>Minimum value: 0. Maximum value: 100. The higher the value the more quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">664</enrollment>
  <condition>Shared Decision Making</condition>
  <condition>Breast Neoplasms</condition>
  <condition>Radiotherapy, Adjuvant</condition>
  <arm_group>
    <arm_group_label>Arm A: Shared decision making</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be informed by a doctor randomized to practice shared decision making and use the in-consultation PtDA during the consultation on adjuvant radiotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B: Usual practice</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be informed by a doctor randomized to inform about adjuvant radiotherapy according to usual practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Shared decision making supported by an in-consultation patient decision aid</intervention_name>
    <description>After having receiving training in SDM, the doctor will practice SDM supported by an in-consultation PtDA during the consultation with the participant.</description>
    <arm_group_label>Arm A: Shared decision making</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Histologically verified breast cancer or ductal carcinoma in situ breast cancer&#xD;
&#xD;
          -  Candidate for adjuvant radiotherapy Danish Breast Cancer Group type F after&#xD;
             breast-conserving surgery for T1-2, N0-Nmi, M0 disease according to national&#xD;
             guidelines.&#xD;
&#xD;
          -  Signed confirmation of participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bilateral breast cancer or suspicion of disseminated cancer&#xD;
&#xD;
          -  Unable to understand the information, the planned treatment or follow-up for any&#xD;
             reason.&#xD;
&#xD;
          -  Earlier radiotherapy towards the thoracic region.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karina D Steffensen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Vejle Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stine R Sondergaard, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vejle Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stine R Sondergaard, M.D.</last_name>
    <phone>+45 79 40 52 92</phone>
    <email>stine.rauff.sondergaard@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg Hospital</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mette Møller, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Mette Møller, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgitte Offersen, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Birgitte Offersen, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claus Kamby, DMSc</last_name>
    </contact>
    <investigator>
      <last_name>Claus Kamby, DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herlev University Hospital</name>
      <address>
        <city>Herlev</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louise W Matthiessen, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Louise W Matthiessen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sjaellands University Hospital</name>
      <address>
        <city>Næstved</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kenneth Hofland, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Kenneth Hofland, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mette H Nielsen, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Mette H Nielsen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stine R Sondergaard, M.D.</last_name>
      <phone>+45 79405292</phone>
      <email>stine.rauff.sondergaard@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 20, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

